These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 24952094)

  • 1. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites.
    Kharbanda EO; Vazquez-Benitez G; Lipkind H; Naleway AL; Klein NP; Cheetham TC; Hambidge SJ; Vellozzi C; Nordin JD
    Prev Med; 2014 Oct; 67():316-9. PubMed ID: 24952094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
    MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
    Kretsinger K; Broder KR; Cortese MM; Joyce MP; Ortega-Sanchez I; Lee GM; Tiwari T; Cohn AC; Slade BA; Iskander JK; Mijalski CM; Brown KH; Murphy TV; ; ;
    MMWR Recomm Rep; 2006 Dec; 55(RR-17):1-37. PubMed ID: 17167397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(40):1302-6. PubMed ID: 20948508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations.
    Sukumaran L; McCarthy NL; Kharbanda EO; McNeil MM; Naleway AL; Klein NP; Jackson ML; Hambidge SJ; Lugg MM; Li R; Weintraub ES; Bednarczyk RA; King JP; DeStefano F; Orenstein WA; Omer SB
    JAMA; 2015 Oct; 314(15):1581-7. PubMed ID: 26501534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1424-6. PubMed ID: 22012116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to Receipt of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Among Mothers of Infants Aged <4 Months with Pertussis - California, 2016.
    New S; Winter K; Boyte R; Harriman K; Gutman A; Christiansen A; Royce S
    MMWR Morb Mortal Wkly Rep; 2018 Sep; 67(38):1068-1071. PubMed ID: 30260942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetanus, diphtheria, pertussis vaccination coverage before, during, and after pregnancy - 16 States and New York City, 2011.
    Ahluwalia IB; Ding H; D'Angelo D; Shealy KH; Singleton JA; Liang J; Rosenberg KD;
    MMWR Morb Mortal Wkly Rep; 2015 May; 64(19):522-6. PubMed ID: 25996094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.
    Fortner KB; Swamy GK; Broder KR; Jimenez-Truque N; Zhu Y; Moro PL; Liang J; Walter EB; Heine RP; Moody MA; Yoder S; Edwards KM
    Vaccine; 2018 Oct; 36(42):6354-6360. PubMed ID: 30219367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes.
    Kharbanda EO; Vazquez-Benitez G; Lipkind HS; Klein NP; Cheetham TC; Naleway A; Omer SB; Hambidge SJ; Lee GM; Jackson ML; McCarthy NL; DeStefano F; Nordin JD
    JAMA; 2014 Nov; 312(18):1897-904. PubMed ID: 25387187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.
    Terranella A; Asay GR; Messonnier ML; Clark TA; Liang JL
    Pediatrics; 2013 Jun; 131(6):e1748-56. PubMed ID: 23713104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(25):468-70. PubMed ID: 22739778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Low Uptake of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Immunization in Privately Insured Women in the United States.
    Butler AM; Layton JB; Li D; Hudgens MG; Boggess KA; McGrath LJ; Weber DJ; Becker-Dreps S
    Obstet Gynecol; 2017 Apr; 129(4):629-637. PubMed ID: 28277354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis vaccination in adult trauma patients: Are we missing an opportunity?
    Yorkgitis BK; Timoney G; Salim A; Berg Pv; Goldberg AJ; Pathak A; Rappold JF
    Surgery; 2015 Sep; 158(3):602-7. PubMed ID: 26032818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections.
    Khodr ZG; Bukowinski AT; Gumbs GR; Conlin AMS
    Vaccine; 2017 Oct; 35(42):5603-5610. PubMed ID: 28916245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.
    Kharbanda EO; Vazquez-Benitez G; Lipkind HS; Klein NP; Cheetham TC; Naleway AL; Lee GM; Hambidge S; Jackson ML; Omer SB; McCarthy N; Nordin JD
    Vaccine; 2016 Feb; 34(7):968-73. PubMed ID: 26765288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.
    Wales DP; Khan S; Suresh D; Ata A; Morris B
    Public Health; 2020 Feb; 179():38-44. PubMed ID: 31726399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.
    Koepke R; Eickhoff JC; Ayele RA; Petit AB; Schauer SL; Hopfensperger DJ; Conway JH; Davis JP
    J Infect Dis; 2014 Sep; 210(6):942-53. PubMed ID: 24903664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.